Nifedipine Articles
Bayvit Launched First Generic Product, In Spain
6 November 1997
Elan Acquires Hypertensives
30 October 1997
Net Income And EPS Soar At Ireland's Elan Corp
22 October 1997
Piramal Sets Up Indian Drug Marketing JV
7 October 1997
Greek Govt Adjusts Prices Of 6,009 Drugs
3 October 1997
New Studies At European Cardiology Meeting
15 September 1997
Bayer Suing Elan For Patent Infringement
4 September 1997
Pfizer Enters New Product Cycle With Strong Potential
7 August 1997
Bayer Opens Pharma Plant In Pakistan
11 July 1997
Bayer Health Care Sales Fueled By Older Products
25 March 1997
Bayer Pharma Starts New Product Cycle
20 March 1997
Strong Earnings Continue At Major US Drug Firms
10 February 1997
Russian Drug Output Fails To Meet Demand
27 January 1997
Benefits Of Bayer's Nisoldipine Shown By DEFIANT II Study
20 January 1997
Zocor "Will Be World's Top-Selling Drug In 2005"
13 January 1997
Astra's Losec "World's No One Drug In 1998-2000"
16 December 1996
Bayer To Begin ACTION Study In Angina
16 December 1996
Biovail Shares Soar On Firm's Good News
9 December 1996
Canadian Drug Licensing Probe Urged
11 November 1996
SkyePharma And BM In Drug Deal
4 November 1996
Major US Drug Cos Post Strong Results In 3rd Qtr
28 October 1996
Net Income Rises 21% in 3rd Qtr At Pfizer
21 October 1996
Frenetic 12 Months For SkyePharma
14 October 1996
Nifedipine Can Help Prevent Stroke
14 October 1996
Bayer Completes $9.5M Venezuela Investment
12 August 1996
US Drug Majors See 2nd-Half Double-Digit Growth
29 July 1996
Bayer Enrolls INSIGHT Study Patients
15 July 1996
Pfizer Rapped Over ADR Reporting
27 May 1996
US Firms' Strong 1st Qtr Lifts Share Prices
29 April 1996
1st-Qtr Sales Driven By New Products At Pfizer
22 April 1996
Rheumatoid Arthritis And Disease Management
22 April 1996
Premarin Heads Top-10 Prescription Drugs
1 April 1996
Bayer Spotlights China For Growth In Asian Markets
1 April 1996
More Restructuring At Bayer Despite Strong 1995
25 March 1996
First Product From Ethical Generics
4 March 1996
Indian drug Price Fixing Moves
26 February 1996
World Markets: Cancer, Cardiovascular, Menopause
19 February 1996
Bayer/Schein Set Up UK Generics Firm
5 February 1996
FDA Panel Verdict On Calcium Blockers
5 February 1996
Mixed Results For Q4 1995 From US Drug Majors
29 January 1996
Bayer To Appeal EU Fine
15 January 1996
All Change For Top Drugs In Year 2000: Lehman Bros
15 January 1996
HRG Seeks Calcium Antagonist Warnings
4 December 1995
Pfizer Presents Fertile Pipeline
6 November 1995
US Drug Cos Reveal Strong Growth In 1995 3rd Qtr
30 October 1995
US 3rd Qrt Results: Strong Gains For Pfizer, Lilly
23 October 1995
Bayer Accused Of Advertising Violation
2 October 1995
Calcium Channel Blocker Debate Continues
11 September 1995
JAMA Study Ups Debate Over Calcium Blockers
4 September 1995
US Economic Slowdown Affects Larger Firms
7 August 1995
Chinese Pharma JV For Bayer
24 July 1995
US Sales of Generic Drugs Up 29% In 1994, Says IMS
17 July 1995
Drug Industry Growth Held Back In Dominican republic
26 June 1995
Benefits Of Drug Delivery Systems For Generics
5 June 1995
Warrick Pharmaceuticals agreement with Novopharm
22 May 1995
Gastrointestinals Top Taiwan Market
8 May 1995
20 Leading US Drugs' Price Increases Slammed
27 March 1995
Calcium Channel Blockers Raise Heart Attack Risk?
20 March 1995
Bayer Expands Production In Spain
13 February 1995
Record Sales For Pfizer In 1994
23 January 1995
NEW YORK STOCK COMMENT
16 January 1995
IMS Studies US Retail Drug Payments
16 January 1995
Polarization Concerns For Chemical/Drug Majors?
16 January 1995
UK Physicians "Unconfident" About CHF Management
19 December 1994
Pfizer, Miles Lawsuit Settled
12 December 1994
Bayer A "Moderate Outperformer"
12 December 1994
Bayer's Profits Rise As Group Refocuses
5 December 1994
MDR: Misunderstood Drug Resistance?
5 December 1994
US FDA Concern over "Therapeutic Class Wars"
28 November 1994
Lower Earnings For Some US Drugmakers In 3rd Qtr
7 November 1994
Solid 3rd Qtr Growth For Large Pharma Cos
31 October 1994
USA's Top-Selling Drugs In 1993
24 October 1994
DDT's New Global Pharma Market Review 1994
10 October 1994
Medeva Beats Expectations At Half Year
12 September 1994
Roche Agrees To Rocephin Settlement But Denies Liability
12 September 1994
FDA, HHS Probe Pharmacy Promos
5 September 1994
Pfizer Found Guilty In Adalat CC Case
5 September 1994
Gensia Halts Protara Trial On Panel Advice
22 August 1994
Second Launch Of Jago Geomatrix System
15 August 1994
Pfizer To Pay Royalties to Bayer
1 August 1994
Strong Gains By US Firms In 2nd Quarter
1 August 1994
Gensia Go-Ahead For Geomatrix Nifedipine
18 July 1994
ANTIHYPERTENSIVES FAIL TROUGH-PEAK CRITERIA
20 June 1994
TAIWAN DRUG MARKET IN 1993
13 June 1994
GENERIC THREAT TO AUGMENTIN IN UK
6 June 1994
BAYER PLANS CHINA PHARMA JV
6 June 1994
CURRENCIES STILL A FACTOR IN US 1st QTR
2 May 1994
RESTRUCTURING PHARMA MARKETING IN JAPAN
2 May 1994
20 BILL YEN TURNOVER GOAL FOR TAIYO
18 April 1994
GENERIC DRUGS AND DELIVERY SYSTEMS
18 April 1994
MILES TO STOP ADALAT WITCH PLAN
18 April 1994
BAYER'S OPTIMISTIC FORECAST FOR 1994
28 March 1994
N AMERICAN PHARMA MARKET STUDIED
28 February 1994
R-PR LAUNCHES THERAPLIX DIVISION
21 February 1994
COST-CONTAINMENT, A BITTER PILL FOR INDUSTRY
21 February 1994
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
